HALOPERIDOL AND REDUCED HALOPERIDOL PLASMA-LEVELS IN SCHIZOPHRENIC-PATIENTS

被引：0
|
作者：
JANN, MW
ERESHEFSKY, L
SAKLAD, SR
RICHARDS, A
DAVIS, CM
机构：
[1] UNIV TEXAS,COLL PHARM,AUSTIN,TX 78712
[2] TEXAS RES INST MENTAL SCI,HOUSTON,TX 77025
来源：
DRUG INTELLIGENCE & CLINICAL PHARMACY | 1984年 / 18卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：507 / 507
页数：1
相关论文
共 50 条
  • [31] THE CLINICAL UTILITY OF HALOPERIDOL PLASMA-LEVELS
    CORYELL, WH
    MILLER, DD
    PERRY, PJ
    SCHIZOPHRENIA RESEARCH, 1995, 15 (1-2) : 146 - 147
  • [32] EFFECTS OF HALOPERIDOL ON CSF GLUTAMATE LEVELS IN DRUG-NAIVE SCHIZOPHRENIC-PATIENTS
    LABARCA, R
    SILVA, H
    JEREZ, S
    RUIZ, A
    RENTERIAS, P
    OGALDE, C
    BUSTOS, G
    SCHIZOPHRENIA RESEARCH, 1995, 16 (01) : 83 - 85
  • [33] DETERMINATION OF HALOPERIDOL AND REDUCED HALOPERIDOL IN THE PLASMA AND BLOOD OF PATIENTS ON DEPOT HALOPERIDOL
    EYLES, DW
    WHITEFORD, HA
    STEDMAN, TJ
    POND, SM
    PSYCHOPHARMACOLOGY, 1992, 106 (02) : 268 - 274
  • [34] EFFECTS OF DEBRISOQUIN AND HALOPERIDOL ON PLASMA HOMOVANILLIC-ACID CONCENTRATION IN SCHIZOPHRENIC-PATIENTS
    DAVIDSON, M
    LOSONCZY, MF
    MOHS, RC
    LESSER, JC
    POWCHIK, P
    FREED, LB
    DAVIS, BM
    MYKYTYN, VV
    DAVIS, KL
    NEUROPSYCHOPHARMACOLOGY, 1987, 1 (01) : 17 - 23
  • [35] THE THERAPEUTIC INDEX OF HALOPERIDOL IN NEWLY ADMITTED SCHIZOPHRENIC-PATIENTS
    VANPUTTEN, T
    MARDER, SR
    MINTZ, J
    PSYCHOPHARMACOLOGY BULLETIN, 1987, 23 (01) : 201 - 205
  • [36] BIOAVAILABILITY OF INTRAMUSCULAR VERSUS ORAL HALOPERIDOL IN SCHIZOPHRENIC-PATIENTS
    SCHAFFER, CB
    SHAHID, A
    JAVAID, JI
    DYSKEN, MW
    DAVIS, JM
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1982, 2 (04) : 274 - 277
  • [37] HALOPERIDOL - PLASMA-LEVELS MONITORING AND HORMONAL RESPONSES
    GOYOT, C
    DEBRAY, Q
    DUGAS, M
    GUAY, C
    GIRAUD, J
    GRENIER, J
    PATHOLOGIE BIOLOGIE, 1985, 33 (10): : 999 - 1004
  • [38] PLASMA-LEVELS OF HALOPERIDOL AND CLINICAL-RESPONSE
    VANPUTTEN, T
    MARDER, SR
    MAY, PRA
    POLAND, RE
    OBRIEN, RP
    PSYCHOPHARMACOLOGY BULLETIN, 1985, 21 (01) : 69 - 72
  • [39] PLASMA-LEVELS OF NEUROLEPTIC DRUGS AND EXTRAPYRAMIDAL SYMPTOMS IN SCHIZOPHRENIC-PATIENTS
    BLOEINK, M
    BERGENER, M
    HESSE, C
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1987, 32 (1-2) : 833 - 833
  • [40] PLASMA-LEVELS AND DOSING STRATEGIES IN SCHIZOPHRENIC-PATIENTS RECEIVING CLOZAPINE
    BUCKLEY, PF
    COLA, PA
    HASEGAWA, N
    LYS, C
    MELTZER, HY
    SCHIZOPHRENIA RESEARCH, 1995, 15 (1-2) : 144 - 145
12345